Sponsor pipeline

Invero Pharma, Inc. clinical trial pipeline

Get alerts when Invero Pharma, Inc.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-16

Active trials by phase

Phase 3
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 3
NCT03176186 Xenon for Neuroprotection During Post-Cardiac Arrest Syndrome in Comatose Survivors of an… Post-Cardiac Arrest Syndrome Not Yet Recruiting 2025-04-03

Disease areas by active trials

Get alerts when Invero Pharma, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free